Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1–2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy

Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1–2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy

BackgroundIt is unclear whether upfront surgery or neoadjuvant chemotherapy is appropriate for first treatment in hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients with 1–2 suspicious axillary lymph node (ALN) metastases on preoperative br...

Full description

Bibliographic Details
Main Authors: Seung Eun Lee, Sung Gwe Ahn, Jung Hwan Ji, Yoonwon Kook, Ji Soo Jang, Seung Ho Baek, Joon Jeong, Soong June Bae
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
breast neoplasm
breast MRI
axillary lymph node metastasis
upfront surgery
neoadjuvant chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.936148/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.936148/full

Similar Items